{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=NERVES&page=9", "query": { "condition": "NERVES", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 7359, "total_pages": 736, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=NERVES&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=NERVES&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T04:42:45.038Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03293940", "title": "Cryoablation for Post Mastectomy Pain Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-Mastectomy Chronic Pain Syndrome (Disorder)" ], "interventions": [ { "name": "Cryoablation", "type": "PROCEDURE" }, { "name": "Therapeutic Peripheral Nerve Block (tPNB) Injection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2018-01-10", "completion_date": "2021-05-19", "has_results": false, "last_update_posted_date": "2021-10-08", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 4, "location_summary": "Atlanta, Georgia • Johns Creek, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Johns Creek", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03293940" }, { "nct_id": "NCT01310218", "title": "Length of Post Operative Dressing After Carpal Tunnel Release", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Carpal Tunnel Syndrome" ], "interventions": [ { "name": "extended postoperative dressing", "type": "OTHER" }, { "name": "short postoperative dressing", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "UConn Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2009-05", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2011-03-08", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 1, "location_summary": "Farmington, Connecticut", "locations": [ { "city": "Farmington", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01310218" }, { "nct_id": "NCT06285097", "title": "A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms", "Non-small-cell Lung Cancer", "Melanoma", "Squamous Cell Carcinoma of the Head and Neck", "Renal Cell Carcinoma", "Urothelial Carcinoma", "Colorectal Carcinoma", "Ovarian Carcinoma" ], "interventions": [ { "name": "PF-07820435", "type": "DRUG" }, { "name": "Sasanlimab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2024-02-08", "completion_date": "2025-02-13", "has_results": false, "last_update_posted_date": "2025-09-17", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 6, "location_summary": "Sarasota, Florida • Grand Rapids, Michigan • Nashville, Tennessee", "locations": [ { "city": "Sarasota", "state": "Florida" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06285097" }, { "nct_id": "NCT02452424", "title": "A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Melanoma", "Non-small Cell Lung Cancer", "Squamous Cell Carcinoma of the Head and Neck", "Gastrointestinal Stromal Tumor (GIST)", "Ovarian Cancer" ], "interventions": [ { "name": "PLX3397", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 78, "start_date": "2015-07-02", "completion_date": "2018-10-12", "has_results": true, "last_update_posted_date": "2020-03-05", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 12, "location_summary": "Scottsdale, Arizona • Greenbrae, California • Los Angeles, California + 7 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Greenbrae", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02452424" }, { "nct_id": "NCT01975324", "title": "A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Non Arteritic Ischemic Optic Neuropathy" ], "interventions": [ { "name": "dalfampridine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neuro-Ophthalmologic Associates, PC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 20, "start_date": "2013-07", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2016-01-25", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01975324" }, { "nct_id": "NCT01996527", "title": "3T MRI Biomarkers of Glioma Treatment Response", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Adult Anaplastic Astrocytoma", "Adult Anaplastic Ependymoma", "Adult Anaplastic Oligodendroglioma", "Adult Giant Cell Glioblastoma", "Adult Glioblastoma", "Adult Gliosarcoma", "Recurrent Adult Brain Tumor" ], "interventions": [ { "name": "3-Tesla magnetic resonance imaging", "type": "DEVICE" }, { "name": "CEST-MRI", "type": "DEVICE" }, { "name": "DW-MRI", "type": "DEVICE" }, { "name": "DCE-MRI", "type": "DEVICE" }, { "name": "DSC-MRI", "type": "DEVICE" }, { "name": "IV administration of gadolinium-containing contrast agent", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Vanderbilt-Ingram Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2012-05", "completion_date": "2016-01-01", "has_results": false, "last_update_posted_date": "2017-04-17", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01996527" }, { "nct_id": "NCT00187109", "title": "Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Germ Cell Tumors", "Hepatic Cancer", "Neuroblastoma", "Osteosarcoma", "Rhabdomyosarcoma" ], "interventions": [ { "name": "Recombinant Human Thrombopoietin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 40, "start_date": "2000-06", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2008-04-10", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00187109" }, { "nct_id": "NCT03636009", "title": "Concurrent Treatment for Patients With Cervical Radiculopathy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Nerve Root Disorder Nos" ], "interventions": [ { "name": "concurrent traction and neuromobilization technique", "type": "OTHER" }, { "name": "sequential traction and neuromobilization technique", "type": "OTHER" }, { "name": "active exercise program", "type": "OTHER" }, { "name": "manual therapy to cervical and thoracic spine", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Indianapolis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2018-10-01", "completion_date": "2019-09-30", "has_results": false, "last_update_posted_date": "2018-10-19", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 1, "location_summary": "Mishawaka, Indiana", "locations": [ { "city": "Mishawaka", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03636009" }, { "nct_id": "NCT02766699", "title": "A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Glioblastoma", "Astrocytoma, Grade IV" ], "interventions": [ { "name": "EGFR(V)-EDV-Dox", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Engeneic Pty Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2016-10-25", "completion_date": "2022-03-30", "has_results": false, "last_update_posted_date": "2025-06-03", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 2, "location_summary": "Baltimore, Maryland • New York, New York", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02766699" }, { "nct_id": "NCT06039709", "title": "Sonodynamic Therapy in Patients With Recurrent GBM", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Glioblastoma", "Glioblastoma Multiforme", "GBM" ], "interventions": [ { "name": "5-ALA and Low-Intensity Focused Ultrasound (SDT)", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Shayan Moosa, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 11, "start_date": "2024-01-31", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-10-27T04:42:45.038Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06039709" } ] }